June 23, 2021
OncoBone contributed to an invited review article to the special issue ‘Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities’ in the Journal ‘Cells’, published on June 17, 2021. The review article titled ‘Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis‘ describes the novel concept of osteoimmuno-oncology (OIO) for the first time. OIO highlights […]
May 28, 2021
OncoBone co-presented in a webinar titled ‘Working with CROs – from selection to managing relationships’ hosted by Biocom on March 30, 2021. OncoBone’s talk covered CRO selection, and featured speakers from Inotiv and Aligos Therapeutics continued about partnerships between CROs and Sponsors. Below is a summary of the key aspects covered in the webinar. There […]
April 27, 2021
OncoBone and Taconic Biosciences will co-present in a webinar titled: ‘Utility of Human Immune System Mice in Metastasis Cancer Drug Development’ on May 4, 2021. Below is a short overview of what to expect from the webinar.
November 13, 2020
Due to COVID-19 pandemic, the year 2020 has been exceptional in many ways. One of the big drawbacks in biomedical research and business has been that all scientific events were transferred to virtual format. OncoBone representatives attended four virtual scientific events this year. In this blog post we summarize our experiences about them and present our hopes for events organized in 2021.
September 1, 2020
OncoBone offers scientific expertise especially in the fields of oncology and bone diseases. In this blog we discuss and comment new scientific discoveries, new accomplishments in drug development and emerging technologies, and biomedical business -related issues.